Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Financial Flexibility Index
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A financial flexibility index. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥43.55 Million (operating CF CN¥26.54 Million minus capex CN¥17.01 Million) represents 0% of total liabilities (CN¥715.31 Million). Explore reinvestment intensity of Shaanxi Panlong Pharmaceutical Group Lim to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
Financial flexibility index of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. Historical Financial Flexibility Index trend for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A across 13 annual periods. Check how aggressively does Shaanxi Panlong Pharmaceutical Group Lim reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Financial Flexibility Index by Year (2013–2025)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A. For the full cash flow conversion analysis, see Shaanxi Panlong Pharmaceutical Group Lim operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥105.42 Million | CN¥63.01 Million | CN¥633.75 Million | ▼ -55.2% |
| 2024 | 0.37x | CN¥238.64 Million | CN¥156.59 Million | CN¥642.84 Million | ▲ +27.9% |
| 2023 | 0.29x | CN¥166.56 Million | CN¥104.05 Million | CN¥573.76 Million | ▲ +57.5% |
| 2022 | 0.18x | CN¥181.20 Million | CN¥125.36 Million | CN¥983.18 Million | ▼ -51.0% |
| 2021 | 0.38x | CN¥196.71 Million | CN¥116.04 Million | CN¥522.97 Million | ▼ -1.7% |
| 2020 | 0.38x | CN¥163.42 Million | CN¥92.24 Million | CN¥426.89 Million | ▼ -4.1% |
| 2019 | 0.40x | CN¥101.44 Million | CN¥67.89 Million | CN¥254.17 Million | ▲ +23.0% |
| 2018 | 0.32x | CN¥66.91 Million | CN¥46.85 Million | CN¥206.24 Million | ▲ +23.4% |
| 2017 | 0.26x | CN¥51.90 Million | CN¥28.45 Million | CN¥197.34 Million | ▼ -41.2% |
| 2016 | 0.45x | CN¥79.05 Million | CN¥61.99 Million | CN¥176.68 Million | ▼ -24.6% |
| 2015 | 0.59x | CN¥85.70 Million | CN¥40.62 Million | CN¥144.44 Million | ▲ +13.6% |
| 2014 | 0.52x | CN¥80.98 Million | CN¥48.56 Million | CN¥155.06 Million | ▲ +22.7% |
| 2013 | 0.43x | CN¥55.99 Million | CN¥25.43 Million | CN¥131.55 Million | — |